GlassScriptPhysician profile
Amy M Durst
NPI 1174025357
$3,526.75
in general payments reported to CMS, 2019-2025
19 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $699 · 2022: $757 · 2023: $125 · 2024: $1,797 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,069 · Food and Beverage: $973 · Education: $28.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,069.26 |
| Food and Beverage | $973.48 |
| Education | $28.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,475.63 | 2024 | Axonics |
| Abbvie INC. | $755.20 | 2021-2023 | |
| Medtronic, INC. | $373.84 | 2021-2025 | Interstim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.68 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $151.76 | 2021-2022 | |
| Janssen Biotech, INC. | $120.21 | 2022 | |
| Boston Scientific Corporation | $114.63 | 2024 | Watchman Access System |
| Gilead Sciences, INC. | $65.54 | 2022 | |
| Organon LLC | $56.71 | 2021-2022 | |
| 180 Medical, INC. | $47.05 | 2021-2023 | Gentlecath |
| Merck Sharp & Dohme LLC | $41.24 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $39.10 | 2021 | |
| Urogen Pharma, INC. | $29.04 | 2023 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $21.30 | 2023 | Lynparza |
| Ironwood Pharmaceuticals, INC | $18.17 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $17.37 | 2021 | |
| Pfizer INC. | $17.24 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.63 | 2021 | |
| Intercept Pharmaceuticals, INC. | $12.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Durst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.